Consumer / Employer, Health Tech Deloitte: 7 Trends Shaping Healthcare and Life Sciences in 2024 By Marissa Plescia
BioPharma, Pharma Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B By Frank Vinluan
Consumer / Employer Viome Life Sciences Secures $86.5M for At-home Tests and Health Products By Marissa Plescia
BioPharma, Pharma How Baxter’s $4B Sale of Biopharma Biz Fits With Broader Life Sciences Trends By Frank Vinluan
Consumer / Employer, BioPharma Viome Life Sciences snags $67M to expand DTC pipeline of at-home tests and wellness products By Marissa Plescia
BioPharma Why a consulting firm focused life sciences bought a healthcare crowdsourcing platform By Joel Berg
Consumer / Employer, Devices & Diagnostics Viome Life Sciences launches at-home oral/throat cancer test for consumers By Marissa Plescia
MedCity Influencers, BioPharma, Legal The year to come in life sciences safety and regulatory practices By Ronan Brown and Joe Rymsza
MedCity Influencers, BioPharma How text messaging is transforming the life sciences industry By J.T. Ripton
BioPharma, Telemedicine Strategies that will help make 2021 a banner year for life sciences industries By J.T. Ripton
Sponsored Post, BioPharma How life sciences companies are re-engaging with customers in the COVID-19 era By MedCity News and Guidehouse
Sponsored Post J.P. Morgan on the state of life sciences and strategies to fuel innovation By Stephanie Baum
MedCity Influencers How digital solutions are transforming healthcare and life sciences business processes By Jay Ramakrishna
BioPharma, Startups Israel’s Arkin Holdings raises $140M for second life sciences investment fund By Alaric DeArment
